-transparent.png){kind=logo}
Ketamine and magnesium (Mg2+), well known bronchodilators, have been used to treat patients with status asthmaticus. Both can block the N-methyl-D-aspartic acid (NMDA) receptor. NMDA receptors exist in the airway, and their activation seems to be linked to the release actions of sensory neuropeptides resulting in increased airway tone. We sought to determine whether ketamine relaxes the guinea pig trachea contracted by histamine by blocking the NMDA receptor. Female guinea pigs (250-400 g) were killed with an overdose of pentobarbital. The trachea was removed and cut spirally into strips 3 mm wide and 15 mm long. The strips were mounted in a 10-mL organ bath filled with Tyrode's solution bubbled through with 95% O2/5% CO2 at 37 degrees C. Strip contractions were measured isometrically with a force displacement transducer. We then studied the effect of NMDA receptor antagonists on histamine-induced tracheal contraction. In this protocol, we examined the effect of ketamine, Mg2+, zinc (Zn2+), or MK-801 (a noncompetitive NMDA receptor blocker) on strips contracted by 10(-5) M histamine. After full contraction was attained, ketamine (0.5-1.5 mM), MgSO4 (2-8 mM), ZnCl2(0.2-0.8 mM), or MK-801 (1.5-6 x 10(-5) M) was added, and the strip tension was measured again. We also studied the effect of NMDA on the relaxation by ketamine. After full contraction by 10(-5) M histamine, 0.5-1.5 mM KET was added alone or in combination with 0.1 mM NMDA, and the strip tension was measured again. Finally, we measured the effect of MK-801 on the relaxant effect of ketamine. After full contraction by 10(-5) M histamine, 0.5-2 mM ketamine was added alone or in combination with 0.75 or 1.5 x 10(-5) M MK-801, and the strip tension was measured again. All NMDA receptor antagonists tested reversed the tracheal contraction induced by histamine in a dose-dependent manner. However, neither the agonist NMDA nor the noncompetitive receptor blocker MK-801 affected tracheal relaxation induced by ketamine. We conclude that ketamine relaxes the tracheal smooth muscle contracted by histamine through a mechanism independent of NMDA receptors. The decreased bronchomotor tone induced by ketamine is probably due to interference with a Ca2+-requiring step necessary to maintain the contraction caused by histamine. CONCLUSIONS Stimulation of the N-methyl-D-aspartic acid (NMDA) receptor in the airway results in airway constriction. The bronchodilator ketamine blocks the NMDA receptor. However, ketamine relaxes the guinea pig trachea contracted by histamine through a mechanism independent of the NMDA receptor.
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
May 1974,
British journal of anaesthesia,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
November 2021,
International journal of molecular sciences,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
August 1988,
The Journal of pharmacology and experimental therapeutics,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
November 2017,
Chinese medical journal,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
July 1994,
Physiological reviews,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
October 2000,
Endocrinology,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
September 2003,
FEBS letters,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
October 1992,
Molecular pharmacology,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
August 2009,
European journal of anaesthesiology,
T Sato, and
K Hirota, and
A Matsuki, and
E K Zsigmond, and
S F Rabito
January 2002,
Pulmonary pharmacology & therapeutics,
